Cargando…

Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study

BACKGROUND: Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. METHODS AND RESULTS: Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study, we assessed the association of incident CAD...

Descripción completa

Detalles Bibliográficos
Autores principales: John, Jenine E., Claggett, Brian, Skali, Hicham, Solomon, Scott D., Cunningham, Jonathan W., Matsushita, Kunihiro, Konety, Suma H., Kitzman, Dalane W., Mosley, Thomas H., Clark, Donald, Chang, Patricia P., Shah, Amil M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496411/
https://www.ncbi.nlm.nih.gov/pubmed/36000416
http://dx.doi.org/10.1161/JAHA.121.021660
_version_ 1784794262328573952
author John, Jenine E.
Claggett, Brian
Skali, Hicham
Solomon, Scott D.
Cunningham, Jonathan W.
Matsushita, Kunihiro
Konety, Suma H.
Kitzman, Dalane W.
Mosley, Thomas H.
Clark, Donald
Chang, Patricia P.
Shah, Amil M.
author_facet John, Jenine E.
Claggett, Brian
Skali, Hicham
Solomon, Scott D.
Cunningham, Jonathan W.
Matsushita, Kunihiro
Konety, Suma H.
Kitzman, Dalane W.
Mosley, Thomas H.
Clark, Donald
Chang, Patricia P.
Shah, Amil M.
author_sort John, Jenine E.
collection PubMed
description BACKGROUND: Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. METHODS AND RESULTS: Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study, we assessed the association of incident CAD with subsequent incident HFpEF (left ventricular ejection fraction [≥50%]) and HF with reduced ejection fraction (HFrEF; left ventricular ejection fraction <50%) using survival models with time‐updated variables. We also assessed the extent to which echocardiographic correlates of prevalent CAD account for the relationship between CAD and incident HFpEF. Over 13‐year follow‐up, incident CAD developed in 892 participants and 178 subsequently developed HF (86 HFrEF, 71 HFpEF). Incident HFrEF and HFpEF risk were both greatest early after the CAD event. At >1 year post‐CAD event, adjusted incidence of HFrEF and HFpEF were similar (7.2 [95% CI, 5.2–10.0] and 6.7 [4.8–9.2] per 1000 person‐years, respectively) and CAD remained predictive of both (HFrEF: hazard ratio, 2.76 [95% CI, 1.99–3.84]; HFpEF: 1.85 [1.35–2.54]) after adjusting for demographics and common comorbidities. Among 4779 HF‐free participants at Visit 5 (2011–2013), the 490 with prevalent CAD had lower left ventricular ejection fraction and higher left ventricular mass index, E/e’, and left atrial volume index (all P<0.01). The association of prevalent CAD with incident HFpEF post‐Visit 5 was not significant after adjusting for echocardiographic measures, with the greatest attenuation observed for left ventricular diastolic function. CONCLUSIONS: CAD is a significant risk factor for incident HFpEF after adjustment for demographics and common comorbidities. This relationship is partially accounted for by echocardiographic alterations, particularly left ventricular diastolic function.
format Online
Article
Text
id pubmed-9496411
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-94964112022-09-30 Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study John, Jenine E. Claggett, Brian Skali, Hicham Solomon, Scott D. Cunningham, Jonathan W. Matsushita, Kunihiro Konety, Suma H. Kitzman, Dalane W. Mosley, Thomas H. Clark, Donald Chang, Patricia P. Shah, Amil M. J Am Heart Assoc Original Research BACKGROUND: Whether coronary artery disease (CAD) is a significant risk factor for heart failure (HF) with preserved ejection fraction (HFpEF) is unclear. METHODS AND RESULTS: Among 9902 participants in the ARIC (Atherosclerosis Risk in Communities) study, we assessed the association of incident CAD with subsequent incident HFpEF (left ventricular ejection fraction [≥50%]) and HF with reduced ejection fraction (HFrEF; left ventricular ejection fraction <50%) using survival models with time‐updated variables. We also assessed the extent to which echocardiographic correlates of prevalent CAD account for the relationship between CAD and incident HFpEF. Over 13‐year follow‐up, incident CAD developed in 892 participants and 178 subsequently developed HF (86 HFrEF, 71 HFpEF). Incident HFrEF and HFpEF risk were both greatest early after the CAD event. At >1 year post‐CAD event, adjusted incidence of HFrEF and HFpEF were similar (7.2 [95% CI, 5.2–10.0] and 6.7 [4.8–9.2] per 1000 person‐years, respectively) and CAD remained predictive of both (HFrEF: hazard ratio, 2.76 [95% CI, 1.99–3.84]; HFpEF: 1.85 [1.35–2.54]) after adjusting for demographics and common comorbidities. Among 4779 HF‐free participants at Visit 5 (2011–2013), the 490 with prevalent CAD had lower left ventricular ejection fraction and higher left ventricular mass index, E/e’, and left atrial volume index (all P<0.01). The association of prevalent CAD with incident HFpEF post‐Visit 5 was not significant after adjusting for echocardiographic measures, with the greatest attenuation observed for left ventricular diastolic function. CONCLUSIONS: CAD is a significant risk factor for incident HFpEF after adjustment for demographics and common comorbidities. This relationship is partially accounted for by echocardiographic alterations, particularly left ventricular diastolic function. John Wiley and Sons Inc. 2022-08-24 /pmc/articles/PMC9496411/ /pubmed/36000416 http://dx.doi.org/10.1161/JAHA.121.021660 Text en © 2022 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Research
John, Jenine E.
Claggett, Brian
Skali, Hicham
Solomon, Scott D.
Cunningham, Jonathan W.
Matsushita, Kunihiro
Konety, Suma H.
Kitzman, Dalane W.
Mosley, Thomas H.
Clark, Donald
Chang, Patricia P.
Shah, Amil M.
Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title_full Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title_fullStr Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title_full_unstemmed Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title_short Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
title_sort coronary artery disease and heart failure with preserved ejection fraction: the aric study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9496411/
https://www.ncbi.nlm.nih.gov/pubmed/36000416
http://dx.doi.org/10.1161/JAHA.121.021660
work_keys_str_mv AT johnjeninee coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT claggettbrian coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT skalihicham coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT solomonscottd coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT cunninghamjonathanw coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT matsushitakunihiro coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT konetysumah coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT kitzmandalanew coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT mosleythomash coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT clarkdonald coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT changpatriciap coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy
AT shahamilm coronaryarterydiseaseandheartfailurewithpreservedejectionfractionthearicstudy